Pharmacoeconomics
Provides a framework for evaluating drug treatments in terms of comparing one treatment with another
Pharmacoeconomic Studies
Designed to only look at economic impact of therapy
-Need to think of clinical impact
Components of well-designed studies
Cost of Illness Analysis
The costs of a specific disease in a given population
Costs of resources needed to treat illness
Costs of nonmedical resources
Loss of productivity
Cost-Minimization Analysis
Compares the costs of two or more treatment alternatives that are considered equal in efficacy
Compares cost of drugs within a class
Cost-Effectiveness Analysis
Two or more treatments/programs that are not necessarily therapeutically equivalent
Measures effectiveness in therapeutic outcomes vs dollars saved
The costs of a specific treatment or intervention are calculated and then compared with the dollar value of the benefit received
Compares and determines the greatest benefit for the dollar spent
Cost Utility Analysis
Costs of the treatment choice are in dollars and the outcomes are expressed in terms of patient preference of quality-adjusted life years
Used when quality of life is a factor
Generic Drugs
Generic drugs may or may not be less expensive
Pharmacy coverage may deteremine whether a generic drug is used
-Tiered benefit
-Lower co-pay for generic drugs
Retail prescription drug programs
Generic Substitution
69% of prescriptions filled with generic drugs
Prescriber influenced by
-Innovator company
-Payer
-Patient
Innovator companies support for health care
Bioequivalence
The U.S. FDA regulates and sets standards for bioequivalence
FDA Orange Book: Approved drug products with therapeutic equivalence evaluations is:
Pharmacoeconomics in Practice
Prescribing generic vs brand name drugs
Pharmacists may substitute a less expensive drug that is therapeutic equivalent
-“dispense as written”
-Patients may switch due to costs and prescription benefit
Retail drug programs
-Walmart, Target, Kroger, Sam’s Club
-$4 for a 30 day supply of common generic drugs
Medicare Part D
Covers 75% of drug costs once the patient pays a deductable of $250/year
In 2018, the gap is $3750 tp $5000 and medicare enrollees get a 65% discount on costs of brand-name drugs and 56% on generic drugs
Prescriptions covered 95% after $5000/year